In 2009, I was diagnosed with multiple sclerosis (MS). In hope of making sense of such an unpredictable disease, I started attending MS conferences, interviewing healthcare professionals and writing articles as author/co-author for publications such as The BMJ, Nature Reviews Neurology and Neurology.

Through my family foundation in Canada, I also began supporting a wide range of MS initiatives including the establishment of the Rachel Horne Prize for Women's Research in MS - an annual award of US$40,000, which recognises a female scientist for her outstanding research into women with MS.

I'm also a patient advocate and am co-chair of the Patient and Public Engagement Group - part of the National Institute of Health Research (NIHR) Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London (QMUL). Since 2022, I have been an Honorary Research Fellow at QMUL.

I am currently on Ocrevus, my third disease modifying therapy to treat my MS.